No impact of parity on global gene expression levels in breast cancer tissue and normal breast tissue – a nested case-control study in the Norwegian Women and Cancer study

Abstract Background We have previously demonstrated that the linear decrease in postmenopausal breast cancer incidence with increasing parity is linked to expression changes in hundreds of genes in the peripheral blood cells of healthy women. However, these changes are not observed in the blood cells of cancer patients. In this study, we conducted a comparative analysis of global gene expression profiles in normal breast tissue and breast cancer tissue, with a focus on parity as the explanatory variable. Methods The Norwegian Women and Cancer (NOWAC) study, a prospective cohort study conducted from 1991 to 2007 and comprising 172,000 participants, was utilized for this work. Women who were enrolled in NOWAC between 2006 and 2010 and had a diagnostic biopsy of breast cancer were requested to provide a second biopsy for research purposes. Furthermore, normal breast tissue was collected from NOWAC participants who were undergoing the national mammographic screening program. The study ultimately consisted of 279 age-matched case-control pairs, with the paired matched design being maintained throughout all laboratory analyses. Differences in tissue gene expression were identified using the Bioconductor R-package limma, utilizing Illumina microarray technology. The intrinsic subtypes were classified in both tissues using the PAM50 gene expression test. Results The findings revealed that nearly all genes displayed significant differential expression between cases and controls, with 10,013 out of 11,308 genes exhibiting statistical significance at an FDR q-value below 0.05. Among these, 5768 genes were upregulated while 4245 genes were downregulated. However, when parity (classified as 0, 1–3, 4–8 children) was incorporated into the model, only three genes in breast cancer tissue exhibited significant changes, while none were observed in normal tissue. Gene set enrichment analyses were non-informative. Furthermore, classification using PAM50 failed to establish any relationship between parity and the different intrinsic subtypes in either tissue. Conclusions Our study revealed no significant differences in gene expression between normal and breast cancer tissue in relation to the number of full-term pregnancies or parity.

Authors

Publication Details

Journal
BMC Cancer
Published
2026-09-29
DOI
https://doi.org/10.1186/s12885-026-17044-5
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

No impact of parity on global gene expression levels in breast cancer tissue and normal breast tissue – a nested case-control study in the Norwegian Women and Cancer study

Sanda Krum‐Hansen, Lill‐Tove Busund, Marit Holden, Karina Standahl Olsen et al.
BMC Cancer
Breast Cancer Treatment Studies
article

No impact of parity on global gene expression levels in breast cancer tissue and normal breast tissue – a nested case-control study in the Norwegian Women and Cancer study

Sanda Krum‐Hansen, Lill‐Tove Busund, Marit Holden, Karina Standahl Olsen, Lund Eiliv, Igor Snapkow, Oxana Gavriluk, Nikita Shvetsov, Lars Holden, Jan Ole Frantzen
article en

Abstract

Abstract Background We have previously demonstrated that the linear decrease in postmenopausal breast cancer incidence with increasing parity is linked to expression changes in hundreds of genes in the peripheral blood cells of healthy women. However, these changes are not observed in the blood cells of cancer patients. In this study, we conducted a comparative analysis of global gene expression profiles in normal breast tissue and breast cancer tissue, with a focus on parity as the explanatory variable. Methods The Norwegian Women and Cancer (NOWAC) study, a prospective cohort study conducted from 1991 to 2007 and comprising 172,000 participants, was utilized for this work. Women who were enrolled in NOWAC between 2006 and 2010 and had a diagnostic biopsy of breast cancer were requested to provide a second biopsy for research purposes. Furthermore, normal breast tissue was collected from NOWAC participants who were undergoing the national mammographic screening program. The study ultimately consisted of 279 age-matched case-control pairs, with the paired matched design being maintained throughout all laboratory analyses. Differences in tissue gene expression were identified using the Bioconductor R-package limma, utilizing Illumina microarray technology. The intrinsic subtypes were classified in both tissues using the PAM50 gene expression test. Results The findings revealed that nearly all genes displayed significant differential expression between cases and controls, with 10,013 out of 11,308 genes exhibiting statistical significance at an FDR q-value below 0.05. Among these, 5768 genes were upregulated while 4245 genes were downregulated. However, when parity (classified as 0, 1–3, 4–8 children) was incorporated into the model, only three genes in breast cancer tissue exhibited significant changes, while none were observed in normal tissue. Gene set enrichment analyses were non-informative. Furthermore, classification using PAM50 failed to establish any relationship between parity and the different intrinsic subtypes in either tissue. Conclusions Our study revealed no significant differences in gene expression between normal and breast cancer tissue in relation to the number of full-term pregnancies or parity.

BMC Cancer
Good health and well-being
Openalex Percentile: Top 15%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.